ROBERTO LUNA: Open Payments
NPI 1942923198 · KNOX, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,892 in 48 payments from 11 companies in 2025. Trend: 2023 $416 · 2024 $488 · 2025 $1,892
Food & beverage: $994Travel & lodging: $899
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 10 | $1,182 |
| Novo Nordisk Inc | 7 | $173 |
| Merck Sharp & Dohme LLC | 7 | $153 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 11 | $125 |
| Amgen Inc. | 4 | $66 |
| PFIZER INC. | 4 | $64 |
| ABIOMED | 1 | $44 |
| BridgeBio Pharma, Inc. | 1 | $32 |
| SCPHARMACEUTICALS INC. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: CARDIOMEMS, Wegovy, VERQUVO, LifeVest, REPATHA, VYNDAQEL, Attruby, FUROSCIX.
Industry payments across IN — which companies pay providers there.
